>
产品中心 >
Growth_factor >
ACROBiosystems/Human CD40 / TNFRSF5 Protein, Fc Tag (MALS verified)/1mg (500ug × 2)/CD0
- SynonymCD40,Bp50,CDW40,MGC9013,TNFRSF5,p50
- SourceHuman CD40 Protein, Fc Tag (MALS verified) (CD0-H5253) is expressed from human 293 cells (HEK293). It contains AA Glu 21 - Arg 193 (Accession # P25942-1).Predicted N-terminus: Glu 21Request for sequence
- Molecular Characterization
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 45.3 kDa. The protein migrates as 50-60 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
- EndotoxinLess than 1.0 EU per μg by the LAL method.
- Purity
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
- Formulation
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehaloseis added as protectant before lyophilization.
Contact us for customized product form or formulation.
- Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
- Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
Human CD40 Protein, Fc Tag (MALS verified) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
The purity of Human CD40 Protein, Fc Tag (MALS verified) (Cat. No.CD0-H5253) was more than 90% and the molecular weight of this protein is around 95-115 kDa verified by SEC-MALS.
Immobilized Human CD40 Ligand, His,Flag Tag (active trimer) (Cat. No. CDL-H52Db) at 5 μg/mL (100 μL/well) can bind Human CD40, Fc Tag (Cat. No. CD0-H5253) with a linear range of 0.02-0.156 μg/mL (QC tested).
Loaded Human CD40, Fc Tag (HPLC-verified) (Cat. No. CD0-H5253) on Protein A Biosensor, can bind Human CD40 Ligand, His,Flag Tag (active trimer) (MALS verified) (Cat. No. CDL-H52Db) with an affinity constant of 1.58 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
FACS analysis shows that Human CD40, Fc Tag (HPLC-verified) (Cat .No. CD0-H5253) can bind to 293T cells overexpressing human CD40L. The concentration of Human CD40 is 0.1 μg/mL (Routinely tested).
- Citations
INDUCIBLE MONOVALENT ANTIGEN BINDING PROTEIN
Authors: Baeuerle Patrick, et al
Journal: US20200148771A1 2020
Application: ELISA
Request for Full-text
ANTI-CD40 ANTIBODY, ANTIGEN BINDING FRAGMENT THEREOF AND MEDICAL USE THEREOF
Authors: Yan Shude , et al
Journal: US20200148778A1 2020
Application: ELISA & Immunization & SPR
Request for Full-text
- BackgroundCD40 is also known as TNFRSF5, Bp50, CDW40, MGC9013, TNFRSF5 andp50, is a member of the TNF receptor superfamily which are single transmembrane-spanning glycoproteins, and plays an essential role in mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. CD40 is a costimulatory protein found on antigen presenting cells and is required for their activation. The binding of CD154 (CD40L) on TH cells to CD40 activates antigen presenting cells and induces a variety of downstream effects. CD40 contains 4 cysteine-rich repeats in the extracellular domain, and is expressed in B cells, dendritic cells, macrophages, endothelial cells, and several tumor cell lines. The extracellular domain has the cysteinerich repeat regions, which are characteristic for many of the receptors of the TNF superfamily. Interaction of CD40 with its ligand, CD40L, leads to aggregation of CD40 molecules,which in turn interact with cytoplasmic components to initiate signaling pathways. Early studies on the CD40-CD40L system revealed its role in humoral immunity. Defects in CD40 result in hyper-IgM immunodeficiency type 3 (HIGM3), an autosomal recessive disorder characterized by an inability of B cells to undergo isotype switching, as well as an inability to mount an antibody-specific immune response, and a lack of germinal center formation.
- References
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.